Dopamine Agonists and Pathologic Behaviors

por Kelley, Brendan J., Duker, Andrew P., Chiu, Peter
Publicado 2012

Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial

por Krikorian, Robert, Shidler, Marcelle D., Summer, Suzanne S., Sullivan, Patrick G., Duker, Andrew P., Isaacson, Richard S., Espay, Alberto J.
Publicado 2019

Effect of Dopaminergic Medication on Postural Sway in Advanced Parkinson’s Disease

por Revilla, Fredy J., Larsh, Travis R., Mani, Ashutosh, Duker, Andrew P., Cox, Cyndy, Succop, Paul, Gartner, Maureen, Jarrin Tejada, Claudia, Bhattacharya, Amit
Publicado 2013

Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit

por Merola, Aristide, Romagnolo, Alberto, Krishna, Vibhor, Pallavaram, Srivatsan, Carcieri, Stephen, Goetz, Steven, Mandybur, George, Duker, Andrew P., Dalm, Brian, Rolston, John D., Fasano, Alfonso, Verhagen, Leo
Publicado 2020

Psychogenic Facial Movement Disorders: Clinical Features and Associated Conditions

por Fasano, Alfonso, Valadas, Anabela, Bhatia, Kailash P, Prashanth, LK, Lang, Anthony E, Munhoz, Renato P, Morgante, Francesca, Tarsy, Daniel, Duker, Andrew P, Girlanda, Paolo, Bentivoglio, Anna Rita, Espay, Alberto J
Publicado 2012

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-anal...

por Artusi, Carlo Alberto, Dwivedi, Alok K., Romagnolo, Alberto, Pal, Gian, Kauffman, Marcelo, Mata, Ignacio, Patel, Dhiren, Vizcarra, Joaquin A., Duker, Andrew, Marsili, Luca, Cheeran, Binith, Woo, Daniel, Contarino, Maria Fiorella, Verhagen, Leonard, Lopiano, Leonardo, Espay, Alberto J., Fasano, Alfonso, Merola, Aristide
Publicado 2019

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)

por Sturchio, Andrea, Marsili, Luca, Vizcarra, Joaquin A., Dwivedi, Alok K., Kauffman, Marcelo A., Duker, Andrew P., Lu, Peixin, Pauciulo, Michael W., Wissel, Benjamin D., Hill, Emily J., Stecher, Benjamin, Keeling, Elizabeth G., Vagal, Achala S., Wang, Lily, Haslam, David B., Robson, Matthew J., Tanner, Caroline M., Hagey, Daniel W., El Andaloussi, Samir, Ezzat, Kariem, Fleming, Ronan M. T., Lu, Long J., Little, Max A., Espay, Alberto J.
Publicado 2020

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial

por Brownstein, Michael J., Simon, Neal G., Long, Jeffrey D., Yankey, Jon, Maibach, Hilda T., Cudkowicz, Merit, Coffey, Christopher, Conwit, Robin A., Lungu, Codrin, Anderson, Karen E., Hersch, Steven M., Ecklund, Dixie J., Damiano, Eve M., Itzkowitz, Debra E., Lu, Shifang, Chase, Marianne K., Shefner, Jeremy M., McGarry, Andrew, Thornell, Brenda, Gladden, Catherine, Costigan, Michele, O’Suilleabhain, Padraig, Marshall, Frederick J., Chesire, Amy M., Deritis, Paul, Adams, Jamie L., Hedera, Peter, Lowen, Kelly, Rosas, H. Diana, Hiller, Amie L., Quinn, Joseph, Keith, Kellie, Duker, Andrew P., Gruenwald, Christina, Molloy, Angela, Jacob, Cara, Factor, Stewart, Sperin, Elaine, Bega, Danny, Brown, Zsazsa R., Seeberger, Lauren C., Sung, Victor W., Benge, Melanie, Kostyk, Sandra K., Daley, Allison M., Perlman, Susan, Suski, Valerie, Conlon, Patricia, Barrett, Matthew J., Lowenhaupt, Stephanie, Quigg, Mark, Perlmutter, Joel S., Wright, Brenton A., Most, Elaine, Schwartz, Guy J., Lamb, Jessica, Chuang, Rosalind S., Singer, Carlos, Marder, Karen, Moran, Joyce A., Singleton, John R., Zorn, Meghan, Wall, Paola V., Dubinsky, Richard M., Gray, Carolyn, Drazinic, Carolyn
Publicado 2020